Study Tempers Promise of Drug for Marfan Syndrome

November 18, 2014

(New York Times) – Now the more objective human evidence is in – results from a large clinical trial testing the experimental drug against the standard treatment. There was no difference in outcomes. The three-year study, published Tuesday in The New England Journal of Medicine, involved 608 participants, aged 6 months to 25 years. The goal was to slow the growth of the aorta, the large blood vessel that carries blood from the heart to the rest of the body.